5Council on Cardiovascular Disease in the Young, Committee on Rheumatic Fever, Endeearditis, and Kawasaki Disease, American Heart Association. Diagnostic guidelines for Kawasaki disease[ J ]. Circulation ,2001,103 (2) :335-336.
6Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [ J ]. Circulation, 2004,110 ( 17 ) :2747 -2771.
7Harada K. Intravenous gamma-globulin treatment in Kawasaki Disease [ J ]. Acta Pediatr Jpn, 1991,33 (6) : 805-810.
8Honkanen VE, McCrindle BW, Laxer RM, et al. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease [ J ]. Pediatr Cardiol,2003,24 (2) : 122-126.
9Anderson MS ,Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome : an analysis of the problem [ J ]. Pediatrics, 2005,115(4) :e428-e433.
10Yasukawa K, Terai M, Shulman ST, et al. Systemic production of vascular endothelial growth factor and fms-likc tyrosine kinase-1 receptor in acute kawasaki disease [ J ], Circulation, 2002. 105(6) :766-769.
